EFFECTOR THERAPEUTICS Trademark

Trademark Overview

On Wednesday, May 16, 2012, a trademark application was filed for EFFECTOR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EFFECTOR THERAPEUTICS trademark a serial number of 85627410. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, January 28, 2023. This trademark is owned by eFFECTOR Therapeutics, Inc.. The EFFECTOR THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; providing medical testing services and information in the field of cancer research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development
effector therapeutics

General Information

Serial Number85627410
Word MarkEFFECTOR THERAPEUTICS
Filing DateWednesday, May 16, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, January 28, 2023
Registration Number5027328
Registration DateTuesday, August 23, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical research; providing medical testing services and information in the field of cancer research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 22, 2012
Primary Code042
First Use Anywhere DateTuesday, July 31, 2012
First Use In Commerce DateTuesday, July 31, 2012

Trademark Owner History

Party NameeFFECTOR Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSolana Beach, CA 92075
Party NameeFFECTOR Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameeFFECTOR Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDel Mar, CA 92014

Trademark Events

Event DateEvent Description
Thursday, September 13, 2012NON-FINAL ACTION E-MAILED
Saturday, May 19, 2012NEW APPLICATION ENTERED
Tuesday, May 22, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 6, 2012ASSIGNED TO EXAMINER
Thursday, September 13, 2012NON-FINAL ACTION WRITTEN
Thursday, September 13, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 14, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 13, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 13, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 13, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 28, 2013ASSIGNED TO LIE
Friday, March 29, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Saturday, August 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 23, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, December 23, 2014SOU EXTENSION 3 FILED
Monday, January 5, 2015SOU EXTENSION 3 GRANTED
Tuesday, January 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 18, 2013SOU TEAS EXTENSION RECEIVED
Wednesday, December 18, 2013SOU EXTENSION 1 FILED
Wednesday, December 18, 2013SOU EXTENSION 1 GRANTED
Friday, December 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 2, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, July 2, 2014SOU EXTENSION 2 FILED
Friday, August 1, 2014SOU EXTENSION 2 GRANTED
Thursday, July 31, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 1, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, July 1, 2015SOU EXTENSION 4 FILED
Friday, May 22, 2015TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, May 22, 2015WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, June 3, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 3, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 14, 2015SOU EXTENSION 4 GRANTED
Wednesday, July 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 24, 2016TEAS STATEMENT OF USE RECEIVED
Friday, June 24, 2016USE AMENDMENT FILED
Wednesday, July 20, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 29, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, December 29, 2015SOU EXTENSION 5 FILED
Thursday, January 14, 2016SOU EXTENSION 5 GRANTED
Friday, January 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 1, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 23, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, January 28, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, January 28, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, January 28, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, July 21, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 23, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 12, 2022TEAS SECTION 8 & 15 RECEIVED
Saturday, August 23, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

therapeutics effector research medical field providing information clinical trials pharmaceutical development pharmaceuticals